Editor's Picks

Articles

Latest
Most Viewed
Most Downloaded
Most Cited
Open Access Case Report
Double heterozygous pathogenic variants in BRCA2 and CHEK2 in a girl with adrenocortical carcinoma
Pediatric adrenocortical tumors (pACTs) are rare endocrine neoplasms with variable prognosis, commonly associated with germline pathogenic variants (PVs) in the tumor suppressor gene TP53. Here, we
Published: April 17, 2025 Explor Endocr Metab Dis. 2025;2:101429
192 8 0
Open Access Commentary
Updates from the 2025 American Diabetes Association guidelines on standards of medical care in diabetes
Diabetes mellitus is a major risk factor for both cardiovascular and chronic kidney disease (CKD) while CKD is also associated with cardiovascular morbidity. In fact, cardiovascular disease is the l
Published: April 15, 2025 Explor Endocr Metab Dis. 2025;2:101428
1074 12 0
Open Access Review
Circulating endocannabinoids and brain anatomy: unraveling the weight loss connection through lifestyle and surgery approaches
Obesity is a multifactorial disease linked to many comorbidities and has an impact on brain health. It is also known that obesity disrupts the endocannabinoid (eCB) system in the central nervous sys
Published: April 07, 2025 Explor Endocr Metab Dis. 2025;2:101427
277 14 0
Open Access Review
Glucocorticoid receptor alpha: origins and functions of the master regulator of homeostatic corrections in health and critical illness
The glucocorticoid receptor alpha (GRα), a vital component of the ancient glucocorticoid (GC) signaling system, is essential for vertebrate survival. It regulates fertility, fetal development, orga
Published: March 28, 2025 Explor Endocr Metab Dis. 2025;2:101426
365 35 0
Open Access Review
Significance of FXR agonists in MASLD treatment: a deep dive into lipid alteration by analytical techniques
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly emerging as a global health crisis, affecting over 30% of the population and demanding urgent attention. This redefined co
Published: March 25, 2025 Explor Endocr Metab Dis. 2025;2:101425
428 42 0
Open Access Review
Healthy adipose tissue after menopause: contribution of balanced diet and physical exercise
The accumulation of adipose tissue is associated with metabolic disorders, including insulin resistance, type 2 diabetes (T2D), dyslipidemia, metabolic syndrome, and cardiovascular diseases (CVD). M
Published: March 13, 2025 Explor Endocr Metab Dis. 2025;2:101424
594 42 0
Open Access Commentary
The 2024 American Diabetes Association guidelines on Standards of Medical Care in Diabetes: key takeaways for laboratory
The escalating prevalence of diabetes poses a significant health concern. Uncontrolled diabetes leads to a multitude of complications. A comprehensive management plan and continual adaptation of gui
Published: July 23, 2024 Explor Endocr Metab Dis. 2024;1:158–166
11245 152 2
Open Access Review
Recent advances in artificial intelligence-assisted endocrinology and diabetes
Artificial intelligence (AI) has gained attention for various reasons in recent years, surrounded by speculation, concerns, and expectations. Despite being developed since 1960, its widespread appli
Published: April 01, 2024 Explor Endocr Metab Dis. 2024;1:16–26
6343 388 4
Open Access Original Article
Glycemic trends, app engagement and achievement of gestational diabetes guideline targets using a diabetes app and Bluetooth® connected blood glucose meters
Aim: Current diabetes guidelines recommend people with gestational diabetes mellitus (PwGDM) use primarily blood glucose meters (BGM) for diabetes management. We evaluated glycemic trends and gui
Published: July 24, 2024 Explor Endocr Metab Dis. 2024;1:167–176
3484 128 0
Open Access Case Report
Beta thalassemia minor: a potential risk factor for osteopenia and osteoporosis
A 74-year-old male patient with beta thalassemia minor presented in 2022 for a follow-up of osteoporosis diagnosed prior to 2004. At the time of presentation, his medical history included: radiation
Published: October 31, 2024 Explor Endocr Metab Dis. 2024;1:213–217
2900 153 0
Open Access Review
Endogenous glucocorticoids during skeletal ageing
Stress hormones, namely glucocorticoids, have diverse actions throughout the body in regulating development, tissue metabolism, inflammation, circadian rhythms, and skeletal homeostasis. While endog
Published: August 16, 2024 Explor Endocr Metab Dis. 2024;1:191–212
2894 162 0
Open Access Review
Adult-onset testosterone deficiency: the usefulness of hormone replacement in reducing mortality in men with this common age-related condition
Adult-onset testosterone deficiency (TD) in men is diagnosed by the finding of low serum testosterone levels and recognised, associated symptoms. The condition has high prevalence in men over 50 yea
Published: June 28, 2024 Explor Endocr Metab Dis. 2024;1:83–100
2724 31 1
Open Access Review
Recent advances in artificial intelligence-assisted endocrinology and diabetes
Artificial intelligence (AI) has gained attention for various reasons in recent years, surrounded by speculation, concerns, and expectations. Despite being developed since 1960, its widespread appli
Published: April 01, 2024 Explor Endocr Metab Dis. 2024;1:16–26
6343 388 4
Open Access Review
Endogenous glucocorticoids during skeletal ageing
Stress hormones, namely glucocorticoids, have diverse actions throughout the body in regulating development, tissue metabolism, inflammation, circadian rhythms, and skeletal homeostasis. While endog
Published: August 16, 2024 Explor Endocr Metab Dis. 2024;1:191–212
2894 162 0
Open Access Case Report
Beta thalassemia minor: a potential risk factor for osteopenia and osteoporosis
A 74-year-old male patient with beta thalassemia minor presented in 2022 for a follow-up of osteoporosis diagnosed prior to 2004. At the time of presentation, his medical history included: radiation
Published: October 31, 2024 Explor Endocr Metab Dis. 2024;1:213–217
2900 153 0
Open Access Case Report
A case series of three patients with extensive lung metastatic pheochromocytoma/paraganglioma: evaluation, treatment challenges, and outcomes
Pheochromocytomas (PCCs) and paragangliomas (PGLs; together PPGLs) are uncommon neuroendocrine tumors arising from adrenal medullary chromaffin cells and sympathetic/parasympathetic paraganglia. Tho
Published: November 15, 2024 Explor Endocr Metab Dis. 2024;1:218–233
1939 153 0
Open Access Commentary
The 2024 American Diabetes Association guidelines on Standards of Medical Care in Diabetes: key takeaways for laboratory
The escalating prevalence of diabetes poses a significant health concern. Uncontrolled diabetes leads to a multitude of complications. A comprehensive management plan and continual adaptation of gui
Published: July 23, 2024 Explor Endocr Metab Dis. 2024;1:158–166
11245 152 2
Open Access Original Article
Glycemic trends, app engagement and achievement of gestational diabetes guideline targets using a diabetes app and Bluetooth® connected blood glucose meters
Aim: Current diabetes guidelines recommend people with gestational diabetes mellitus (PwGDM) use primarily blood glucose meters (BGM) for diabetes management. We evaluated glycemic trends and gui
Published: July 24, 2024 Explor Endocr Metab Dis. 2024;1:167–176
3484 128 0
Open Access Original Article
Waist-to-height ratio as a novel marker of metabolic syndrome in patients with type 2 diabetes mellitus
Aim: Metabolic syndrome (MetS) is associated with chronic conditions, including type 2 diabetes mellitus (T2DM) and cardiovascular disorders. New markers are needed for the early detection and su
Published: January 10, 2025 Explor Endocr Metab Dis. 2025;2:101421
1307 96 6
Open Access Review
Recent advances in artificial intelligence-assisted endocrinology and diabetes
Artificial intelligence (AI) has gained attention for various reasons in recent years, surrounded by speculation, concerns, and expectations. Despite being developed since 1960, its widespread appli
Published: April 01, 2024 Explor Endocr Metab Dis. 2024;1:16–26
6343 388 4
Open Access Original Article
Development of adrenal 3-dimensional spheroid cultures: potential for the treatment of adrenal insufficiency and neurodegenerative diseases
Aim: Regenerative and curative strategies would be desirable for neurodegenerative and adrenal diseases, and multipotent adrenal stem cells are considered as promising biological tools for this p
Published: April 01, 2024 Explor Endocr Metab Dis. 2024;1:27–38
2477 53 2
Open Access Commentary
The 2024 American Diabetes Association guidelines on Standards of Medical Care in Diabetes: key takeaways for laboratory
The escalating prevalence of diabetes poses a significant health concern. Uncontrolled diabetes leads to a multitude of complications. A comprehensive management plan and continual adaptation of gui
Published: July 23, 2024 Explor Endocr Metab Dis. 2024;1:158–166
11245 152 2
Open Access Original Article
Testosterone undecanoate is associated with improved ageing male symptoms score in men with type 2 diabetes and adult-onset testosterone deficiency: re-analyzed results from a randomised controlled trial
Aim: To evaluate changes in quality of life via the ageing male symptom scale (AMSS) and somatic, psychological, and sexual sub-scales following testosterone undecanoate (TU) or placebo (P) treat
Published: August 13, 2024 Explor Endocr Metab Dis. 2024;1:177–190
1326 25 2
Open Access Review
Application of chimeric antigen receptor-natural killer cells for the treatment of type 1 diabetes
For the past 100 years, insulin supplementation has been the mainstay of treatment for type 1 diabetes (T1D), which is characterized by progressive autoimmune-mediated loss of insulin-producing β c
Published: April 01, 2024 Explor Endocr Metab Dis. 2024;1:4–11
1943 30 1

Membership

Journal Indexing
Journal Metrics
Article Usage (total)

Views: 59,155

Downloads: 1,974

Follow the Journal